20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY
#1502METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
#1503Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino] ethanethiol formulation
#1504STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#1505DAPTOMYCIN FORMULATIONS AND USES THEREOF
#1506COMPOSITIONS THAT METABOLIZE OR SEQUESTER FREE SUGAR MONOMERS AND USES THEREOF
#1507Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#1508BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#1509NOVEL COMPLEXES COMPRISING COLLAGEN PEPTIDES AND CURCUMINOIDS AND COMPOSITIONS THEREOF
#1510Cleavable lipids
#1511Bispecific antibody formulation
#1512Lentiviral vector-based Japanese encephalitis immunogenic composition
#1513IL-15 protein complex pharmaceutical composition
#1514High potency stable formulations of vaginal
#1515EXOSOME COMPOSITION AND METHOD OF MANUFACTURE
#1516Pharmaceutical Compositions, Methods for Preparation using Lipid Vesicle Particles of Defined Size, and Uses Thereof
#1517PHARMACEUTICAL COMPOSITION COMPRISING PCSK-9 ANTIBODY AND USE THEREOF
#1518Vial stopper for a lyophilization vial and closure method for closing a lyophilization vial
#1519Stable IGG4 Based Binding Agent Formulations
#1520Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereof
#1521Therapeutic microbiota for the treatment and/or prevention of food allergy
#1522Compositions comprising bacterial strains
#1523Biologic preserving composition and methods of use
#1524CANNABINOID FORMULATIONS FOR TREATING ALCOHOL HANGOVER
#1525RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
#1526Methods of treating ulcerative colitis
#1527Compositions comprising a bacterial strain of the genus and uses thereof
#1528Compositions comprising bacterial strains
#1529HOMOGENEOUS POLYSACCHARIDE ESP-B4, DERIVED FROM HERBA EPHEDRA, PREPARATION METHOD AND MEDICAL USE THEREOF
#1530Physiologically balanced injectable formulations of fosnetupitant
#1531COMPOSITIONS AND METHODS OF USE OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
#1532Formulations for intravenous administration
#1533SOST antibody pharmaceutical composition and uses thereof
#1534Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders
#1535PHARMACEUTICAL COMPOSITIONS COMPRISING PEPTIDE VARIANTS AND METHODS OF USE THEREOF
#1536S. SPINOSUM EXTRACT FOR TREATING FATTY LIVER DISEASE
#1537Preparation of B4 for injection
#1538METHODS, COMPOSITIONS AND CONTAINERS FOR REDUCING SOLID FORM QUERCETIN DEGRADATION AND 2-(3,4-DIHYDROXYBENZOYLOXY)-4,6-DIHYDROXYBENZOIC ACID TOXIC BYPRODUCTS THEREOF
#1539METHODS, COMPOSITIONS AND CONTAINERS FOR REDUCING SOLID FORM QUERCETIN DEGRADATION AND 2,4,6-TRIHYDROXYBENZOIC ACID TOXIC BYPRODUCT THEREOF
#1540Selective RARγ ligand-loaded nanoparticles for manipulation of targeted bone growth
#1541Technology for Preparation of Macromolecular Microspheres
#1542Polyomavirus neutralizing antibodies
#1543Dried composition
#1544In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid
#1545Nanoparticles Containing a Taxane and Their Use
#1546USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#1547for the treatment of mood disorders
#1548Compositions comprising bacterial strains
#1549AMORPHOUS POWDER COMPRISING AN ANGIOTENSIN RECEPTOR BLOCKER AND A NEUTRAL ENDOPEPTIDASE INHIBITOR
#1550Process for lyophilising a product
#1551Inhalable antimicrobial particles and methods of making the same
#1552DRY INTRAVENOUS POWDER COMPOSITIONS AND USES THEREOF
#1553Drug compound and purification methods thereof
#1554Formulations comprising recombinant acid alpha-glucosidase
#1555HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS
#1556Compositions comprising bacterial strains
#1557Compositions and methods for the treatment of allergy
#1558COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1559VIABLE LYOPHILIZED COMPOSITIONS DERIVED FROM HUMAN TISSUES AND METHODS OF MAKING THE SAME
#1560UMBILICAL CORD BLOOD SERUM AND UMBILICAL CORD BLOOD PLASMA PREPARATION IN COMBINATION WITH A NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND FREEZE-DRYING THE COMPOSITION
#1561Freeze dried active composition and a system for using the same
#1562Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
#1563Pharmaceutical composition containing botulinum neurotoxin
#1564TREATMENT OF HUMAN METAPNEUMOVIRUS
#1565POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#1566Nucleic acid vector tablets
#1567LIPID NANOPARTICLE MRNA VACCINES
#1568Freeze-drying methods and related products
#1569RNA interference delivery formulation and methods for malignant tumors
#1570TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR
#1571Vaccine compositions
#1572Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
#1573Drug formulations
#1574Process for Hydrating Cyclophosphamide Freeze-Dried Composition and Product Thereof
#1575ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES
#1576Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof
#1577Sunitinib formulations and methods for use thereof in treatment of glaucoma
#1578MAGNETIC NANOPARTICLES FOR TARGETED DELIVERY
#1579A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE
#1580Composition for injection
#1581Liquid feeding device for the generation of droplets
#1582NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#1583SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION
#1584Compositions comprising bacterial strains
#1585FORMULATIONS OF BRINCIDOFOVIR
#1586Compositions of different densities for fast disintegrating multi-layer tablet
#1587Pharmaceutical formulation containing gelling agent
#1588IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
#1589VEGF antagonist formulations suitable for intravitreal administration
#1590PHARMACEUTICAL COMPOSITION COMPRISING C-MET ANTIBODY-DRUG CONJUGATE AND USE THEREOF
#1591ANTIBODY DRUG CONJUGATES
#1592PURIFIED POLLEN PARTICLES AND USE THEREOF FOR ADMINISTERING NANOSYSTEMS
#1593Compositions comprising bacterial strains
#1594Compositions and methods of treatment with amniotic fluid
#1595PHARMACEUTICAL NANOSUSPENSION FOR THE THERAPY OF HIV INFECTION
#1596Pharmaceutical composition comprising selexipag
#1597Viral vector stabilization
#1598Process for the preparation of epoprostenol sodium of enhanced stability
#1599Lyophilized preparation of cytotoxic dipeptides
#1600Methods And Means For Protecting The Skin Against Pathogenic Microorganisms
#1601METHODS AND COMPOSITIONS RELATING TO ISOLATED AND PURIFIED MICROBES
#1602Compositions and methods for the treatment of metabolic conditions
#1603Non-injectable hydrogel formulations for smart release
#1604CNS delivery of therapeutic agents
#1605IN SITU CELL DELIVERY USING RECONSTITUTED PHOTOPOLYMERIZED CHONDROITIN SULFATE GLYCOSAMINOGLYCAN HYDROGEL MATRICES
#1606Multi chamber flexible bag and methods of using same
#1607Albumin pharmaceutical composition and preparation method therefor
#1608KIT FOR PREPARING INJECTABLE CARMUSTINE SOLUTIONS
#1609Angiopoietin 2, VEGF dual antagonists
#1610Recombinant clusterin and use thereof in the treatment and prevention of disease
#1611Subcutaneous administration of ADAMTS13
#1612Compositions comprising extract of poplar buds and uses thereof
#1613USE OF LIPOSOMES FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B
#1614Compositions and methods for the induction of CD8+ T-cells
#1615COMPOSITIONS AND METHODS FOR TREATMENT OF LOSS OF FLUIDS LEADING TO HYPOTENSION AND/OR HYPOVOLEMIA
#1616Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
#1617MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
#1618LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
#1619Formulations and methods for lyophilization and lyophilates provided thereby
#1620Compositions containing systems of release of carbon dioxide obtained from plant juices
#1621Combination vaccine for swine
#1622COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#1623Nanoparticle vaccine adjuvant and methods of use thereof
#1624Method for blood plasma protein activity preservation
#1625Methods of treatment using alpha-1-antitrypsin compositions
#1626Factor VIII formulations
#1627COMPOSITIONS AND METHODS FOR THERAPY WITH DENGUE VIRUS
#1628Oral dosage form
#1629BLOOD PLASMA-CONTAINING COMPOSITIONS
#1630PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN
#1631Method for drying hydrogel comprising nanofibrillar cellulose and a dried hydrogel comprising nanofibrillar cellulose
#1632PHARMACEUTICAL FORMULATIONS OF SUVOREXANT
#1633C1-esterase inhibitor preparation
#1634STABILIZED FORMULATIONS OF LIPID NANOPARTICLES
#1635Vaccine delivery systems using yeast cell wall particles
#1636Microparticles and nanoparticles having negative surface charges
#1637Method for producing flavonoid inclusion compound
#1638HYDROXAMIC ACID PRODRUG COMPOUND OR SALT THEREOF, LYOPHILIZED FORMULATION, LPXC INHIBITOR, AND ANTIBACTERIAL AGENT
#1639Docetaxel and human serum albumin complexes
#1640METHOD OF TREATING OVERWEIGHT OR OBESITY COMPRISING ADMINISTERING A PLEUROTUS OSTREATUS MUSHROOM EXTRACT OR A COMPOSITION COMPRISING A PLEUROTUS OSTRETUS MUSHROOM EXTRACT
#1641Probiotic compositions containing clostridiales for inhibiting inflammation
#1642Compositions comprising bacterial strains
#1643PHARMACEUTICAL FORMULATION CONTAINING TADALAFIL
#1644CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD
#1645High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#1646ACTIVE SUBSTANCE OF LACTOBACILLUS PLANTARUM GKM3, A COMPOSITION COMPRISING THEREOF AND ITS USE FOR PROMOTING LONGEVITY
#1647Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving allergic asthma
#1648Therapeutic formulation for reduced drug side effects
#1649PHARMACEUTICAL COMPOSITION FOR IN VIVO DELIVERY, METHOD OF PREPARATION OF A SUBSTANTIALLY WATER-INSOLUBLE PHARMACOLOGICALLY ACTIVE AGENT FOR IN VIVO DELIVERY, AND METHOD OF TREATING DISEASE
#1650N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
#1651Pharmaceutical composition
#1652Room temperature stable lyophilized protein
#1653Stabilised Compositions of Factor VII Polypeptides
#1654Methods and compositions for CNS delivery of iduronate-2-sulfatase
#1655Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#1656Nano-crystallized herbal ingredient-containing package and method of preparing herbal decoction
#1657P-ethoxy nucleic acids for STAT3 inhibition
#1658IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#1659Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128
#1660Compositions and methods for treating diverticulitis and related disorders
#1661Thrombin solution and methods of use thereof
#1662DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY
#1663System and method and device for adjusting image positioning
#1664Synthetic platelets
#1665Composition for treating fibrocartilage tissue damage
#1666Sol-gel/hydrogel therapeutic delivery system and methods thereof
#1667Method for manufacturing freeze-dried body and manufacturing device for same
#1668Reduced viscosity protein pharmaceutical formulations
#1669Lyophilized pharmaceutical compositions for naked DNA gene therapy
#1670Pharmaceutical composition comprising plasminogen and uses thereof
#1671Pharmaceutical composition comprising a sulfonylurea drug and preparation method thereof
#1672Antimicrobial compositions
#1673Polycarbonate containing compounds and methods related thereto
#1674VEGF antagonist formulations suitable for intravitreal administration
#1675Liquid pharmaceutical composition
#1676Methods and compositions for treating ulcerative colitis
#1677Formulation and Process for Modulating Wound Healing
#1678BIOACTIVE COMPOUNDS PROTECTION METHOD AND COMPOSITIONS CONTAINING THE SAME
#1679COMPOSITION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#1680Agonist of spexin-based galanin type 2 receptor and use thereof
#1681LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES
#1682Ceftolozane antibiotic compositions
#1683Heat stable vaccines
#1684Orodispersible tablet containing burlulipase and pharmaceutical composition produced therefrom
#1685Means and methods for oral protein delivery
#1686Knee pain evaluation and management via WOMAC and KOOS systems
#1687Isolation of human lung progenitors derived from pluripotent stem cells
#1688Method of managing joint pain
#1689Sulfoximine glycosidase inhibitors
#1690Bioengineered lactobacillus probiotics and the uses thereof
#1691Urtica dioica extracts and methods of isolating urtica dioica extracts
#1692Pharmaceutical compositions comprising meloxicam
#1693Nanoparticles for controlled release of Sorafenib and Sorafenib derivatives
#1694Methods and formulations for reducing reconstitution time of lyophilized polypeptides
#1695Methods and compositions for inhibiting cancer cell growth
#1696Radiopharmaceutical compositions of radioactive halogenated benzylguanidine
#1697Formulations of VEG antagonist fusion proteins and method of manufacturing them
#1698Formulation, dosage form and method of reducing knee pain
#1699Composition for cough
#1700Substituted dihydrobenzofuran glycosidase inhibitors
#1701STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#1702Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone
#1703Compositions and methods for promoting a healthy microbial flora in a mammal
#1704Methods and means for protecting the skin against pathogenic microorganisms
#1705Compositions and methods for treating and preventing graft versus host disease
#1706Compositions and methods for the induction of CD8+ T-cells
#1707Thermostable vaccine compositions and methods of preparing same
#1708Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
#1709QUINOLONE ANALOGS AND THEIR SALTS, COMPOSITIONS, AND METHOD FOR THEIR USE
#1710Process for Preparing Water Soluble Azadiractin Powder Formulation with In-Built and External Inclusion Complexes
#1711Site-specific conjugation of linker drugs to antibodies and resulting ADCS
#1712Site-specific conjugation of linker drugs to antibodies and resulting ADCS
#1713NOVEL STABLE FORMULATION FOR FXIA ANTIBODIES
#1714Highly concentrated pharmaceutical formulations
#1715Use of the FL118 core chemical structure platform to generate FL118 derivatives for treatment of human disease
#1716Formulation
#1717Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
#1718Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#1719Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions
#1720Poly(ketals) and related compositions and methods
#1721RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS OF USE
#1722STABLE PHARMACEUTICAL FORMULATIONS OF METHYLNALTREXONE
#1723PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#1724Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#1725PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII
#1726Compositions for the treatment of articular disorders
#1727METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#1728Preparation of dry formulations of dairy probiotics
#1729Injectable Combination Products Of Fosaprepitant And 5-HT3 Blocker
#1730Fast disintegrating pharmaceutical composition
#1731COLLAGEN-BASED THERAPEUTIC DELIVERY SYSTEMS
#1732STRUCTURES AND METHODS FOR GENE THERAPY
#1733Coating of Nanoparticle Surfaces with Cyclopeptides for Improving Delivery of Agents Via the Oral Route
#1734Non-protein clostridial toxin compositions
#1735Treatment of respiratory tract diseases and infections with ascorbic acid compositions
#1736Placental tissue component compositions for treatment of skin defects and methods using same
#1737A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT
#1738Risperidone sustained release microsphere composition
#1739COMPOSITIONS COMPRISING POORLY WATER SOLUBLE PHARMACEUTICAL AGENTS AND ANTIMICROBIAL AGENTS
#1740INSULIN FORMULATIONS FOR RECONSTITUTION INTO HIGH CONCENTRATION LIQUID SOLUTIONS
#1741COMPLEX FOR DRUG DELIVERY AND STABILIZATION AND PREPARATION METHOD THEREOF
#1742DRIED MICROORGANISM WITH EXCIPIENT
#1743Polymer particles
#1744Lyophilized preparation
#1745Probiotic compositions containing clostridiales for inhibiting inflammation
#1746PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS
#1747Injectable pharmaceutical composition of tecovirimat and preparation method thereof
#1748Stabilized formulations of lipid nanoparticles
#1749Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
#1750GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#1751Stabilised Solid Compositions of Factor VII Polypeptides
#1752PHARMACEUTICAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, USE OF A PEPTIDE, USE OF A PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DISEASES ASSOCIATED WITH INTRAOCULAR HYPERTENSION OR GLAUCOMA
#1753Chinese medicinal composition that expels parasitic Toxoplasma gondii and a method of preparing the same
#1754Pharmaceutical formulation
#1755PARTICLES, PHARMACEUTICAL PREPARATION, TOPICAL DRUG, AND COSMETIC PRODUCT
#1756Microparticles for Oral Delivery
#1757CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF
#1758Anti-CD19 antibody formulations
#1759DIPYRIDYL ALKALOID, PREPARATION METHOD THEREFOR AND USE THEREOF
#1760MATERIALS AND METHODS FOR TREATING REGIONAL PAIN
#1761Formulation for administration of RNA
#1762ACORUS GRAMINEUS AS A PHARMACOLOGICALLY ACTIVE NATURAL TREATMENT IN THE ADDICTION OF NICOTINE
#1763Methods of treating, reducing the incidence of, and/or preventing ischemic events
#1764SN-38 loaded iron crosslinked micelle and methods thereof
#1765Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
#1766FORMULATIONS OF ANTIBODY
#1767Duocarmycin ADCs showing improved in vivo antitumor activity
#1768Viscosity reduction of highly concentrated protein formulations
#1769Dilutable formulations of cannabinoids and processes for their preparation
#1770Cleavable lipids
#1771Remote loading of sparingly water-soluble drugs into liposomes
#1772Hydrobromide of benzodiazepine derivative, preparation method and use thereof
#1773Caspofungin compositions for inhalation
#1774STABILISATION OF VIRAL PARTICLES
#1775FORMULATIONS OF ROLAPITANT
#1776Composition for treatment of disorders
#1777Process Of Improving Water Solubility Of Sesamin
#1778Lipid formulations of carmustine
#1779Hydrogel Compositions
#1780Saposin C pharmaceutical compositions and methods of treating cancer
#1781Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
#1782Albumin-free botulinum toxin formulations
#1783High purity oritavancin and method of producing same
#1784Probiotic recolonisation therapy
#1785Methods of treating arthritis
#1786Polysaccharide and methods
#1787PHARMACEUTICAL COMPOSITION COMPRISING PURPLE CORN EXTRACT FOR PREVENTION OR TREATMENT OF SKIN DISEASE
#1788Method for preparing anti-obesity composition by using astringent persimmons and mandarin peels
#1789Preparation of respirable zafirlukast particles
#1790Pharmaceutical parenteral formulation containing carglumic acid
#1791Process to reduce endotoxin in gelatin
#1792Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose
#1793STERILE INJECTABLE COMPOSITION COMPRISING CARFILZOMIB
#1794SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS
#1795STERILE INJECTABLE COMPOSITION COMPRISING MELPHALAN
#1796Drug and layered silicate composite with improved oral bioavailability, oral pharmacological composition containing the composite and method for producing the composite
#1797Methods for the treatment of thyroid eye disease
#1798Uses of IL-13 antagonists for treating atopic dermatitis
#1799Oral Composition of Anti-TNF-Alpha Antibodies
#1800Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid